These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30338083)

  • 1. Ability of suvorexant to prevent delirium in patients in the intensive care unit: a randomized controlled trial.
    Azuma K; Takaesu Y; Soeda H; Iguchi A; Uchida K; Ohta S; Mishima S; Inoue T; Inoue Y; Oda J
    Acute Med Surg; 2018 Oct; 5(4):362-368. PubMed ID: 30338083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suvorexant is associated with a low incidence of delirium in critically ill patients: a retrospective cohort study.
    Masuyama T; Sanui M; Yoshida N; Iizuka Y; Ogi K; Yagihashi S; Nagatomo K; Sasabuchi Y; Lefor AK
    Psychogeriatrics; 2018 May; 18(3):209-215. PubMed ID: 29423967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive Effects of Suvorexant on Delirium: A Randomized Placebo-Controlled Trial.
    Hatta K; Kishi Y; Wada K; Takeuchi T; Ito S; Kurata A; Murakami K; Sugita M; Usui C; Nakamura H;
    J Clin Psychiatry; 2017; 78(8):e970-e979. PubMed ID: 28767209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the delirium preventive effect of dual orexin receptor antagonist (DORA) in critically ill adult patients requiring ventilation with tracheal intubation at an advanced emergency center: A single-center, retrospective, observational study.
    Matsuoka A; Sogawa R; Murakawa-Hirachi T; Mizoguchi Y; Monji A; Shimanoe C; Shinada K; Koami H; Sakamoto Y
    Gen Hosp Psychiatry; 2023; 83():123-129. PubMed ID: 37182281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol for a randomised controlled trial evaluating the effects of the orexin receptor antagonist suvorexant on sleep architecture and delirium in the intensive care unit.
    Azimaraghi O; Hammer M; Santer P; Platzbecker K; Althoff FC; Patrocinio M; Grabitz SD; Wongtangman K; Rumyantsev S; Xu X; Schaefer MS; Fuller PM; Subramaniam B; Eikermann M
    BMJ Open; 2020 Jul; 10(7):e038474. PubMed ID: 32690536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-World Preventive Effects of Suvorexant in Intensive Care Delirium: A Retrospective Cohort Study.
    Izuhara M; Izuhara HK; Tsuchie K; Araki T; Ito T; Sato K; Miura S; Otsuki K; Nagahama M; Hayashida M; Hashioka S; Wake R; Kimura T; Tsumoto S; Saito Y; Inagaki M
    J Clin Psychiatry; 2020 Oct; 81(6):. PubMed ID: 33027560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing the effect of immortal time bias affects the analysis of prevention of delirium by suvorexant in critically ill patients: A retrospective cohort study.
    Shiotsuka J; Uchino S; Sasabuchi Y; Masuyama T; Lefor AK; Sanui M
    PLoS One; 2022; 17(12):e0277916. PubMed ID: 36454811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Suvorexant and Lemborexant for the Prevention of Delirium in Adult Critically Ill Patients at an Advanced Critical Care Center: A Single-Center, Retrospective, Observational Study.
    Matsuoka A; Tobita S; Sogawa R; Shinada K; Murakawa-Hirachi T; Shimanoe C; Monji A; Mizoguchi Y; Miike T; Sakamoto Y
    J Clin Psychiatry; 2022 Nov; 84(1):. PubMed ID: 36350599
    [No Abstract]   [Full Text] [Related]  

  • 9. Real-World Effectiveness of Ramelteon and Suvorexant for Delirium Prevention in 948 Patients With Delirium Risk Factors.
    Hatta K; Kishi Y; Wada K; Takeuchi T; Hashimoto N; Suda K; Taira T; Tsuchida K; Ohmori T; Akizuki N; Nishio Y; Nakanishi Y; Usui C; Kurata A; Horikawa N; Eguchi H; Ito S; Muto H; Nakamura H; Uchimura N
    J Clin Psychiatry; 2019 Dec; 81(1):. PubMed ID: 31851436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poststroke delirium incidence and outcomes: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU).
    Mitasova A; Kostalova M; Bednarik J; Michalcakova R; Kasparek T; Balabanova P; Dusek L; Vohanka S; Ely EW
    Crit Care Med; 2012 Feb; 40(2):484-90. PubMed ID: 22001583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of suvorexant in the prevention of delirium during acute hospitalization: A systematic review.
    Adams AD; Pepin MJ; Brown JN
    J Crit Care; 2020 Oct; 59():1-5. PubMed ID: 32480359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suvorexant with or without ramelteon to prevent delirium: a systematic review and meta-analysis.
    Tian Y; Qin Z; Han Y
    Psychogeriatrics; 2022 Mar; 22(2):259-268. PubMed ID: 34881812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Low-Dose Prophylactic Quetiapine on Delirium Prevention in Critically Ill Patients: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study.
    Kim Y; Kim HS; Park JS; Cho YJ; Yoon HI; Lee SM; Lee JH; Lee CT; Lee YJ
    J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31892105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial.
    Hatta K; Kishi Y; Wada K; Takeuchi T; Odawara T; Usui C; Nakamura H;
    JAMA Psychiatry; 2014 Apr; 71(4):397-403. PubMed ID: 24554232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU).
    Ely EW; Margolin R; Francis J; May L; Truman B; Dittus R; Speroff T; Gautam S; Bernard GR; Inouye SK
    Crit Care Med; 2001 Jul; 29(7):1370-9. PubMed ID: 11445689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of halopeRIdol to decrease the burden of Delirium In adult Critically ill patiEnts (EuRIDICE): study protocol for a prospective randomised multi-centre double-blind placebo-controlled clinical trial in the Netherlands.
    Smit L; Trogrlić Z; Devlin JW; Osse RJ; Ponssen HH; Slooter AJC; Hunfeld NGM; Rietdijk WJR; Gommers D; van der Jagt M;
    BMJ Open; 2020 Sep; 10(9):e036735. PubMed ID: 32967873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suvorexant for the prevention of delirium: A meta-analysis.
    Xu S; Cui Y; Shen J; Wang P
    Medicine (Baltimore); 2020 Jul; 99(30):e21043. PubMed ID: 32791676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Dexamethasone and Delirium in Critically Ill Patients: A Retrospective Cohort Study of a Large Clinical Database.
    Wu Z; Li H; Liao K; Wang Y
    J Surg Res; 2021 Jul; 263():89-101. PubMed ID: 33639374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of delirium assessments in critically ill children: A prospective, observational study during routine care.
    Paterson RS; Kenardy JA; Dow BL; De Young AC; Pearson K; Aitken LM; Long DA
    Aust Crit Care; 2021 May; 34(3):226-234. PubMed ID: 33909556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole for prevention of delirium in the neurosurgical intensive care unit: a double-blind, randomized, placebo-controlled study.
    Mokhtari M; Farasatinasab M; Jafarpour Machian M; Yaseri M; Ghorbani M; Ramak Hashemi SM; Nikoobakht M; Golchin N; Mohammadi G; Sistanizad M
    Eur J Clin Pharmacol; 2020 Apr; 76(4):491-499. PubMed ID: 31900543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.